erlotinib hydrochloride has been researched along with bacteriochlorin in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (bacteriochlorin) | Trials (bacteriochlorin) | Recent Studies (post-2010) (bacteriochlorin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 130 | 0 | 90 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, H; Cacaccio, J; Cheruku, RR; Dukh, M; Durrani, FA; Guru, K; Kalinski, P; Koya, RC; Missert, JR; Pandey, RK; Siters, K; Tabaczynski, WA; Tracy, EC; Watson, R | 1 |
1 other study(ies) available for erlotinib hydrochloride and bacteriochlorin
| Article | Year |
|---|---|
Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coculture Techniques; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Mice; Mice, SCID; Photochemotherapy; Photosensitizing Agents; Porphyrins; Stereoisomerism; Structure-Activity Relationship; Survival Rate | 2021 |